These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 22547615)

  • 1. Systematic analysis of metallo-β-lactamases using an automated database.
    Widmann M; Pleiss J; Oelschlaeger P
    Antimicrob Agents Chemother; 2012 Jul; 56(7):3481-91. PubMed ID: 22547615
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Lactamase Engineering Database: a critical survey of TEM sequences in public databases.
    Thai QK; Bös F; Pleiss J
    BMC Genomics; 2009 Aug; 10():390. PubMed ID: 19698099
    [TBL] [Abstract][Full Text] [Related]  

  • 3. SHV Lactamase Engineering Database: a reconciliation tool for SHV β-lactamases in public databases.
    Thai QK; Pleiss J
    BMC Genomics; 2010 Oct; 11():563. PubMed ID: 20942904
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sulfamoyl Heteroarylcarboxylic Acids as Promising Metallo-β-Lactamase Inhibitors for Controlling Bacterial Carbapenem Resistance.
    Wachino JI; Jin W; Kimura K; Kurosaki H; Sato A; Arakawa Y
    mBio; 2020 Mar; 11(2):. PubMed ID: 32184250
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Acquired metallo-β-lactamases and their genetic association with class 1 integrons and ISCR elements in Gram-negative bacteria.
    Zhao WH; Hu ZQ
    Future Microbiol; 2015; 10(5):873-87. PubMed ID: 26000655
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An in silico approach for understanding the molecular evolution of clinically important metallo-beta-lactamases.
    Pal A; Tripathi A
    Infect Genet Evol; 2013 Dec; 20():39-47. PubMed ID: 23954421
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Probing the Interaction of Aspergillomarasmine A with Metallo-β-lactamases NDM-1, VIM-2, and IMP-7.
    Bergstrom A; Katko A; Adkins Z; Hill J; Cheng Z; Burnett M; Yang H; Aitha M; Mehaffey MR; Brodbelt JS; Tehrani KHME; Martin NI; Bonomo RA; Page RC; Tierney DL; Fast W; Wright GD; Crowder MW
    ACS Infect Dis; 2018 Feb; 4(2):135-145. PubMed ID: 29091730
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diversity and Proliferation of Metallo-β-Lactamases: a Clarion Call for Clinically Effective Metallo-β-Lactamase Inhibitors.
    Somboro AM; Osei Sekyere J; Amoako DG; Essack SY; Bester LA
    Appl Environ Microbiol; 2018 Sep; 84(18):. PubMed ID: 30006399
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multiyear, Multinational Survey of the Incidence and Global Distribution of Metallo-β-Lactamase-Producing Enterobacteriaceae and Pseudomonas aeruginosa.
    Kazmierczak KM; Rabine S; Hackel M; McLaughlin RE; Biedenbach DJ; Bouchillon SK; Sahm DF; Bradford PA
    Antimicrob Agents Chemother; 2016 Feb; 60(2):1067-78. PubMed ID: 26643349
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of a new metallo-beta-lactamase gene, bla(NDM-1), and a novel erythromycin esterase gene carried on a unique genetic structure in Klebsiella pneumoniae sequence type 14 from India.
    Yong D; Toleman MA; Giske CG; Cho HS; Sundman K; Lee K; Walsh TR
    Antimicrob Agents Chemother; 2009 Dec; 53(12):5046-54. PubMed ID: 19770275
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Virtual Screening and Experimental Testing of B1 Metallo-β-lactamase Inhibitors.
    Kang JS; Zhang AL; Faheem M; Zhang CJ; Ai N; Buynak JD; Welsh WJ; Oelschlaeger P
    J Chem Inf Model; 2018 Sep; 58(9):1902-1914. PubMed ID: 30107123
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Structural Insights for Core Scaffold and Substrate Specificity of B1, B2, and B3 Metallo-β-Lactamases.
    Yun Y; Han S; Park YS; Park H; Kim D; Kim Y; Kwon Y; Kim S; Lee JH; Jeon JH; Lee SH; Kang LW
    Front Microbiol; 2021; 12():752535. PubMed ID: 35095785
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of Verona Integron-Borne Metallo-β-Lactamase (VIM) Variants Reveals Differences in Stability and Inhibition Profiles.
    Makena A; Düzgün AÖ; Brem J; McDonough MA; Rydzik AM; Abboud MI; Saral A; Çiçek AÇ; Sandalli C; Schofield CJ
    Antimicrob Agents Chemother; 2015 Dec; 60(3):1377-84. PubMed ID: 26666919
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 1,4,7-Triazacyclononane Restores the Activity of β-Lactam Antibiotics against Metallo-β-Lactamase-Producing
    Somboro AM; Amoako DG; Osei Sekyere J; Kumalo HM; Khan R; Bester LA; Essack SY
    Appl Environ Microbiol; 2019 Feb; 85(3):. PubMed ID: 30478231
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Elucidating the Role of Residue 67 in IMP-Type Metallo-β-Lactamase Evolution.
    LaCuran AE; Pegg KM; Liu EM; Bethel CR; Ai N; Welsh WJ; Bonomo RA; Oelschlaeger P
    Antimicrob Agents Chemother; 2015 Dec; 59(12):7299-307. PubMed ID: 26369960
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mutation S115T in IMP-Type Metallo-β-Lactamases Compensates for Decreased Expression Levels Caused by Mutation S119G.
    Zhang CJ; Faheem M; Dang P; Morris MN; Kumar P; Oelschlaeger P
    Biomolecules; 2019 Nov; 9(11):. PubMed ID: 31718049
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The structure of the metallo-β-lactamase VIM-2 in complex with a triazolylthioacetamide inhibitor.
    Christopeit T; Yang KW; Yang SK; Leiros HK
    Acta Crystallogr F Struct Biol Commun; 2016 Nov; 72(Pt 11):813-819. PubMed ID: 27834790
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Insight into stereochemistry of a new IMP allelic variant (IMP-55) metallo-β-lactamase identified in a clinical strain of Acinetobacter baumannii.
    Shakibaie MR; Azizi O; Shahcheraghi F
    Infect Genet Evol; 2017 Jul; 51():118-126. PubMed ID: 28336429
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Biochemical Characterization of QPX7728, a New Ultrabroad-Spectrum Beta-Lactamase Inhibitor of Serine and Metallo-Beta-Lactamases.
    Tsivkovski R; Totrov M; Lomovskaya O
    Antimicrob Agents Chemother; 2020 May; 64(6):. PubMed ID: 32152086
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In Silico Fragment-Based Design Identifies Subfamily B1 Metallo-β-lactamase Inhibitors.
    Cain R; Brem J; Zollman D; McDonough MA; Johnson RM; Spencer J; Makena A; Abboud MI; Cahill S; Lee SY; McHugh PJ; Schofield CJ; Fishwick CWG
    J Med Chem; 2018 Feb; 61(3):1255-1260. PubMed ID: 29271657
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.